Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Romilkimab Biosimilar - Anti-IL13, IL4 mAb - Research Grade |
---|---|
Source | IMGT/mAb-DB 794 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | LC: 36kDa HC: 63kDa |
Purity | >85% |
Buffer | PBS pH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Romilkimab,Romilkimab,IL13, IL4,anti-IL13, IL4 |
Reference | PX-TA1027 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | [VH-VH' Gamma1 + VL-VL' kappa (bispecific) |
Clonality | Monoclonal Antibody |
Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4 antibody that binds and neutralizes IL-4/IL-13 making it ideal for exploration in fibrosis, This product is for research use only.
Romilkimab Biosimilar - Anti-IL13, IL4 mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Reviews
Il n’y a pas encore d’avis.